Diametric Capital’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
Diametric Capital's DYN Position: Q3 2026 in Review
Diametric Capital opened a new position in Dyne Therapeutics (DYN) in Q3 2026: 15,254 shares worth $246K. The stake represents 0.02% of the portfolio and ranks #476 among its holdings.
270 funds tracked by Wall St. Rank hold DYN as of Q3 2026.
- Diametric Capital held 15,254 shares of Dyne Therapeutics worth $246K as of Q3 2026.
- Dyne Therapeutics was a new Diametric Capital position in Q3 2026.
- Dyne Therapeutics made up 0.02% of Diametric Capital's portfolio in Q3 2026, its #476 holding.
- 270 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.
Based on Diametric Capital's 13F filing for Q3 2026, filed 16 Nov 2026.